Eisai Co., Ltd. (4523.T)
JPY 3727.0
(0.84%)
JPY 3727.0
(0.84%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 53.4 Billion JPY | 16.76% |
| 2022 | 40.04 Billion JPY | -25.51% |
| 2021 | 53.75 Billion JPY | 3.83% |
| 2020 | 51.76 Billion JPY | -58.75% |
| 2019 | 125.5 Billion JPY | 45.67% |
| 2018 | 86.15 Billion JPY | 11.58% |
| 2017 | 77.21 Billion JPY | 30.73% |
| 2016 | 59.06 Billion JPY | 13.73% |
| 2015 | 51.93 Billion JPY | 83.27% |
| 2014 | 28.33 Billion JPY | -60.15% |
| 2013 | 71.1 Billion JPY | 0.91% |
| 2012 | 70.46 Billion JPY | -26.41% |
| 2011 | 95.74 Billion JPY | -15.35% |
| 2010 | 113.11 Billion JPY | 30.91% |
| 2009 | 86.4 Billion JPY | -5.88% |
| 2008 | 91.8 Billion JPY | 417.26% |
| 2007 | 17.74 Billion JPY | -83.14% |
| 2006 | 105.26 Billion JPY | 9.99% |
| 2005 | 95.7 Billion JPY | 10.25% |
| 2004 | 86.8 Billion JPY | 4.51% |
| 2003 | 83.06 Billion JPY | 9.49% |
| 2002 | 75.86 Billion JPY | 4.37% |
| 2001 | 72.68 Billion JPY | 23.26% |
| 2000 | 58.96 Billion JPY | 58.8% |
| 1999 | 37.13 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 13.4 Billion JPY | 107.52% |
| 2023 Q2 | 5.4 Billion JPY | -79.25% |
| 2023 FY | 46.75 Billion JPY | 16.76% |
| 2023 Q4 | 6.46 Billion JPY | 5.74% |
| 2023 Q3 | 6.11 Billion JPY | 13.15% |
| 2023 Q1 | 26.02 Billion JPY | -0.72% |
| 2022 FY | 40.04 Billion JPY | -25.51% |
| 2022 Q2 | -2.18 Billion JPY | -129.34% |
| 2022 Q3 | 8.57 Billion JPY | 492.94% |
| 2022 Q4 | 26.21 Billion JPY | 205.92% |
| 2022 Q1 | 7.43 Billion JPY | 135.74% |
| 2021 FY | 53.75 Billion JPY | 3.83% |
| 2021 Q2 | 5.49 Billion JPY | -90.08% |
| 2021 Q1 | 55.4 Billion JPY | 1035.14% |
| 2021 Q3 | 13.64 Billion JPY | 148.19% |
| 2021 Q4 | -20.8 Billion JPY | -252.43% |
| 2020 Q1 | 32.12 Billion JPY | -38.42% |
| 2020 FY | 51.76 Billion JPY | -58.75% |
| 2020 Q2 | 1.95 Billion JPY | -93.9% |
| 2020 Q4 | -5.92 Billion JPY | -125.09% |
| 2020 Q3 | 23.61 Billion JPY | 1105.31% |
| 2019 Q3 | 41.32 Billion JPY | 567.53% |
| 2019 FY | 125.5 Billion JPY | 45.67% |
| 2019 Q1 | 25.82 Billion JPY | -11.07% |
| 2019 Q4 | 52.16 Billion JPY | 26.24% |
| 2019 Q2 | 6.19 Billion JPY | -76.03% |
| 2018 Q4 | 29.04 Billion JPY | 232.26% |
| 2018 Q2 | 27.79 Billion JPY | 35.03% |
| 2018 Q1 | 20.58 Billion JPY | -32.55% |
| 2018 Q3 | 8.74 Billion JPY | -68.55% |
| 2018 FY | 86.15 Billion JPY | 11.58% |
| 2017 FY | 77.21 Billion JPY | 30.73% |
| 2017 Q3 | 18.96 Billion JPY | 50.54% |
| 2017 Q2 | 12.59 Billion JPY | -16.75% |
| 2017 Q1 | 15.13 Billion JPY | 959.8% |
| 2017 Q4 | 30.51 Billion JPY | 60.88% |
| 2016 Q2 | 12.77 Billion JPY | -50.51% |
| 2016 FY | 59.06 Billion JPY | 13.73% |
| 2016 Q3 | 19.04 Billion JPY | 49.08% |
| 2016 Q1 | 25.81 Billion JPY | 684.86% |
| 2016 Q4 | 1.42 Billion JPY | -92.5% |
| 2015 Q1 | 7.61 Billion JPY | 68.8% |
| 2015 Q2 | 10.46 Billion JPY | 37.45% |
| 2015 Q4 | 3.28 Billion JPY | -89.24% |
| 2015 Q3 | 30.57 Billion JPY | 192.14% |
| 2015 FY | 51.93 Billion JPY | 83.27% |
| 2014 Q1 | 8.46 Billion JPY | -70.06% |
| 2014 Q4 | 4.51 Billion JPY | -22.34% |
| 2014 Q2 | 9.55 Billion JPY | 12.86% |
| 2014 Q3 | 5.8 Billion JPY | -39.23% |
| 2014 FY | 28.33 Billion JPY | -60.15% |
| 2013 Q2 | 26.31 Billion JPY | 85.92% |
| 2013 FY | 71.1 Billion JPY | 0.91% |
| 2013 Q4 | 28.28 Billion JPY | 11586.36% |
| 2013 Q3 | 242 Million JPY | -99.08% |
| 2013 Q1 | 14.15 Billion JPY | -13.37% |
| 2012 Q3 | 16.78 Billion JPY | -7.74% |
| 2012 Q4 | 16.33 Billion JPY | -2.67% |
| 2012 Q1 | 19.14 Billion JPY | 41.47% |
| 2012 FY | 70.46 Billion JPY | -26.41% |
| 2012 Q2 | 18.19 Billion JPY | -4.97% |
| 2011 Q4 | 13.53 Billion JPY | -57.4% |
| 2011 Q2 | 28.23 Billion JPY | 27.09% |
| 2011 FY | 95.74 Billion JPY | -15.35% |
| 2011 Q1 | 22.21 Billion JPY | 503.18% |
| 2011 Q3 | 31.76 Billion JPY | 12.52% |
| 2010 Q1 | 32.77 Billion JPY | 2336.65% |
| 2010 Q4 | 3.68 Billion JPY | -91.28% |
| 2010 FY | 113.11 Billion JPY | 30.91% |
| 2010 Q3 | 42.24 Billion JPY | 22.74% |
| 2010 Q2 | 34.41 Billion JPY | 5.02% |
| 2009 Q3 | 35.94 Billion JPY | 43.91% |
| 2009 Q4 | 1.34 Billion JPY | -96.26% |
| 2009 FY | 86.4 Billion JPY | -5.88% |
| 2009 Q1 | 24.14 Billion JPY | 31.27% |
| 2009 Q2 | 24.97 Billion JPY | 3.44% |
| 2008 Q3 | 26.87 Billion JPY | 19.52% |
| 2008 FY | 91.8 Billion JPY | 417.26% |
| 2008 Q1 | 24.06 Billion JPY | 0.0% |
| 2008 Q2 | 22.48 Billion JPY | -6.56% |
| 2008 Q4 | 18.39 Billion JPY | -31.55% |
| 2007 FY | 17.74 Billion JPY | -83.14% |
| 2006 FY | 105.26 Billion JPY | 9.99% |
| 2005 FY | 95.7 Billion JPY | 10.25% |
| 2004 FY | 86.8 Billion JPY | 4.51% |
| 2003 FY | 83.06 Billion JPY | 9.49% |
| 2002 FY | 75.86 Billion JPY | 4.37% |
| 2001 FY | 72.68 Billion JPY | 23.26% |
| 2000 FY | 58.96 Billion JPY | 58.8% |
| 1999 FY | 37.13 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | -944.553% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 75.052% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 115.079% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 68.851% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 27417.133% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | -70.165% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | -461.421% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -7359.218% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | -305.62% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | -820.352% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -2619.348% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 10911.336% |
| Tsumura & Co. | 20.01 Billion JPY | -166.8% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -1229.549% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | -960.524% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | -202.629% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -1284.344% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | -449.655% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | -788.209% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 1834.589% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -1271.546% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 6680.03% |
| MedRx Co., Ltd | -933 Million JPY | 5824.33% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | -936.648% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 4789.025% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 2353.502% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | -721.662% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | -182.791% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 7757.753% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | -176.282% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -1118.717% |